On April 13, 2026, the American Academy of Sleep Medicine published new recommendations on combining treatments for chronic insomnia. Meditation played no part in its main finding. “Our analysis suggests that CBT-I by itself is the most efficacious first-line treatment for insomnia,” said lead author Dr. Daniel J. Buysse of the University of Pittsburgh. That leaves a question for anyone with a sleep app on their phone: do meditation apps improve sleep, or do they just feel like they should?
The guideline most sleep specialists work from doesn’t take a position on mindfulness. The AASM’s 2021 guideline gave multicomponent CBT-I a strong recommendation for chronic insomnia in adults. It gave relaxation therapy a conditional one. For mindfulness, the authors found fewer than three studies meeting their inclusion criteria, so they made no recommendation. A 2019 guideline from the Department of Veterans Affairs and Department of Defense reached a similar conclusion: not enough evidence to know whether mindfulness meditation is helpful for people with insomnia.
It recommends against adding medication to CBT-I rather than using CBT-I alone, because behavioral treatment “often produces meaningful and durable improvements without the added risks associated with pharmacotherapy.” Both of its recommendations are conditional and rest on low certainty of evidence. The disclosures matter here: Buysse has consulted for pharmaceutical and digital health companies and received research support from Sleep Number. Task force member Wickwire has received industry research support and sits on the AASM board.
The American College of Physicians reached the same conclusion earlier. On May 3, 2016, it named CBT-I the first-line treatment for adults with chronic insomnia. The ACP noted that CBT-I can be delivered through telephone or web-based modules and self-help books. Digital CBT-I programs fit that description. Meditation apps don’t.
Digital CBT-I programs offer a specific point of comparison: one example is SleepioRx, a prescription software-based mobile app that delivers a computerized version of CBT-I, which received FDA clearance on Aug. 8, 2024, for treating chronic insomnia as an adjunct to usual care in adults. More broadly, when on-site or local CBT-I resources are limited, such as extended wait lists, digital CBT-I delivered through websites and apps is suggested as a step before therapist-delivered CBT-I, with some programs offered as independent self-help resources and others professionally or AI/ML guided, or offered as a hybrid support model.
| Date | Event | Impact |
|---|---|---|
| 2017 | AASM guideline (aasm.org) | Drugs and CBT-I as separate options |
| 2019 | VA/DoD guideline (nccih.nih.gov) | Mindfulness evidence insufficient |
| 2019 | Mindfulness meta-analysis (nccih.nih.gov) | Beat education-based controls |
| 2021 | AASM guideline (nccih.nih.gov) | No recommendation on mindfulness |
| April 13, 2026 | AASM combination guideline (aasm.org) | CBT-I alone favored |
The strongest positive evidence comes from a meta-analysis that started with 3,303 records and kept 18 trials with 1,654 participants. It included only trials with active comparison groups. Mindfulness meditation improved sleep quality more than education-based treatments. Its effects were no different from those of CBT and exercise. That sounds encouraging, but the authors rated the strength of evidence as low. At 5 to 12 months of follow-up, they described their results as preliminary evidence for a long-term effect.
Other studies point in different directions. A 2022 review of 20 studies and 2,890 participants found mindfulness-based stress reduction might be ineffective for sleep quality in people with insomnia. Its authors noted that the studies were small and showed bias. A 2015 trial of 60 adults aged 75 and older with chronic insomnia suggested the same program could help that age group.
Keep in mind what these reviews tested: mindfulness meditation as a practice, not any particular app.
| Study | Sample | Design | Finding |
|---|---|---|---|
| 2022 review (nccih.nih.gov) | 20 studies, 2,890 people | Small, biased studies | MBSR may be ineffective |
| 2015 RCT (nccih.nih.gov) | 60 adults, age 75+ | Randomized trial | MBSR possibly useful |
| Calm survey (pmc.ncbi.nlm.nih.gov) | Calm subscribers | Cross-sectional, self-report | Use linked to better sleep |
There’s less randomized evidence for the apps themselves. One trial enrolled 239 adults with Insomnia Severity Index scores of 10 or higher and little or no meditation experience. Researchers measured outcomes at baseline, four weeks and eight weeks. The meditation group showed more improvement in depression and anxiety than the control group. Those gains came through improvements in pre-sleep arousal. That’s useful, but the trial’s main outcomes were mood measures, not sleep, and eight weeks is a short follow-up.
The Calm study, often cited as evidence that the app works, was a cross-sectional survey of subscribers. It was not a trial. Users rated whether the app had “very much improved,” “somewhat improved,” or caused “no noticeable improvement” in their sleep. Every component was associated with improvements in sleep, with one exception: general meditations at night were not associated with falling asleep faster. The authors also acknowledge there is no research on how Sleep Stories might work. Paying subscribers rating their own improvement is weak evidence. Treat it as a reason to run trials, not as proof.
CBT-I can be expensive and inaccessible, and its sleep-restriction component may worsen some psychiatric symptoms. The authors suggested mindfulness as a second-line option when first-line treatments aren’t viable or tolerable. In practice, an app may make sense for someone whose main problem is a racing mind at bedtime, someone with mild sleep trouble, or someone waiting to start CBT-I. Mindfulness is usually considered low-risk, although few studies have looked closely at possible harms.
A clinician is the better choice once symptoms meet the definition of chronic insomnia: occurring at least three nights a week for at least three months and causing real distress or impairment. That affects roughly 6 to 10 percent of adults. ACP’s Wayne J. Riley has urged doctors to look for treatable causes such as depression, pain, sleep apnea and restless legs syndrome. No meditation track will fix sleep apnea.
The research supports a narrow claim: mindfulness practice can significantly improve sleep quality compared with nonspecific active controls. It doesn’t support marketing apps as a replacement for CBT-I, which both the ACP and the AASM still put first. It’s reasonable to expect that better app trials, with sleep outcomes and longer follow-up, would sharpen this picture, but that’s a guess, not a finding. Until those trials exist, a meditation app can help some people sleep, but it isn’t a treatment for chronic insomnia.